- Home
- IMPP vs RGC Comparison
IMPP vs RGC Comparison
Compare IMPP & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.65
HOLD
Current Price
$22.16
Company Overview
Basic Information| Metric | IMPP | RGC |
|---|---|---|
| Founded | 1981 | 2014 |
| Country | Greece | Hong Kong |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.7M | 9.8B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | IMPP | RGC |
|---|---|---|
| Price | $3.65 | $22.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 884.8K | 338.7K |
| Earning Date | 12-11-2025 | 10-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.03 | N/A |
| Revenue | ★ $136,071,654.00 | N/A |
| Revenue This Year | $7.55 | N/A |
| Revenue Next Year | $58.58 | N/A |
| P/E Ratio | $3.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.12 | $0.09 |
| 52 Week High | $6.57 | $83.60 |
Technical Indicators
Market Signals| Indicator | IMPP | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 30.58 | 60.11 |
| Support Level | $3.50 | $19.80 |
| Resistance Level | $3.84 | $25.50 |
| Average True Range (ATR) | 0.20 | 2.61 |
| MACD | -0.01 | 0.36 |
| Stochastic Oscillator | 14.65 | 54.27 |
Price Performance
Historical Comparison IMPP
RGC
About IMPP Imperial Petroleum Inc.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.